Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
BRCAness and prostate cancer: diagnostic and therapeutic considerations.
Prostate cancer and prostatic diseases
Utility of novel androgen receptor therapies in the real world: A nuanced approach.
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous R...
This study will evaluate the efficacy and safety of olaparib (MK-7339) monotherapy in participants with multiple types of advanced cancer (unresectable and/or metastatic) that: 1) have progressed or been intolerant t...